IMNM Operating Cash Flow Growth
Immunome Inc · Operating Cash Flow Growth
IMNM Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-16.85%period ending
IMNM TTM Cash from Operations YoY % (-26.40% → -16.85%)
Year-over-year change
High-resolution chart · PNG
IMNM operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -16.8511% | |
| -28.7027% | |
| -72.3189% | |
| -114.6648% | |
| -194.6619% | |
| -255.8039% | |
| -1,363.9799% | |
| -2,786.8142% | |
| -1,526.4879% | |
| -2,408.284% | |
| 73.6215% | |
| 111.1342% | |
| 116.7455% | |
| 108.8242% | |
| -57.4125% | |
| -64.8001% | |
| -60.0025% | |
| -54.8475% | |
| -50.206% | |
| -102.0922% | |
| -87.0549% | |
| -45.7731% | |
| -26.3958% |